...
首页> 外文期刊>Bioorganic and medicinal chemistry >Structure-based virtual screening against SARS-3CL(pro) to identify novel non-peptidic hits.
【24h】

Structure-based virtual screening against SARS-3CL(pro) to identify novel non-peptidic hits.

机译:Structure-based virtual screening against SARS-3CL(pro) to identify novel non-peptidic hits.

获取原文
获取原文并翻译 | 示例
           

摘要

Severe acute respiratory syndrome is a highly infectious upper respiratory tract disease caused by SARS-CoV, a previously unidentified human coronavirus. SARS-3CL(pro) is a viral cysteine protease critical to the pathogen's life cycle and hence a therapeutic target of importance. The recently elucidated crystal structures of this enzyme provide an opportunity for the discovery of inhibitors through rational drug design. In the current study, Gold docking program was utilized to conduct extensive docking studies against the target crystal structure to develop a robust and predictive docking protocol. The validated docking protocol was used to conduct a structure-based virtual screening of the Asinex Platinum collection. Biological evaluation of a screened selection of compounds was carried out to identify novel inhibitors of the viral protease.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号